ArcticZymes Technologies ASA (0DRV.L)

25,95 -0,15 (-0,57%) Alla chiusura: 03:19PM BST

ArcticZymes Technologies ASA

Sykehusveien 23
SIVA Innovation Centre PO Box 6463
Tromsø 9294
Norway
47 77 64 89 00
https://arcticzymes.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Marie Ann Roskrow BSc. (Hons), MBBS (Hons), Ph.D.	Executive Chairman	500k	N/D	N/D
Mr. Borge Sorvoll	Chief Financial Officer	1,75M	N/D	1975
Dr. Marit Sjo Lorentzen	Vice President of Operations	1,26M	N/D	1968
Mr. Dirk Hahneiser	Vice President of Business Development & Marketing	1,57M	N/D	1968
Mr. Michael Benjamin Akoh	Chief Executive Officer	N/D	N/D	1973
Dr. Jeremy Gillespie	Vice President of Corporate Development	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in NOK.

Descrizione

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Governance aziendale

L'ISS Governance QualityScore di ArcticZymes Technologies ASA al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.